NEO - NEOGENOMICS INC

7.19
-0.570   -7.928%

Share volume: 1,692,658
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$7.76
-0.57
-0.07%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 1%
Dept financing 11%
Liquidity 67%
Performance 17%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-11.23%
1 Month
-24.32%
3 Months
-41.54%
6 Months
-7.46%
1 Year
-25.26%
2 Year
-54.26%
Key data
Stock price
$7.19
P/E Ratio 
0.00
DAY RANGE
$7.18 - $7.72
EPS 
-$0.76
52 WEEK RANGE
$4.72 - $13.74
52 WEEK CHANGE
-$24.24
MARKET CAP 
1.522 B
YIELD 
N/A
SHARES OUTSTANDING 
129.812 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-29-2025
BETA 
1.58
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,599,197
AVERAGE 30 VOLUME 
$1,689,644
Company detail
CEO: Christopher M. Smith
Region: US
Website: neogenomics.com
Employees: 2,100
IPO year: 2004
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited.

Recent news